Jason Napodano works at Zacks and covers stocks such as AMRN. He posted his workup on $PLX valuation, being "generous" on the pipeline and sales.His price estimate? See for yourselfhttp://twitpic.com/9gr0rd/full$5.95LEARN TO TRADE--Dave
Just stop replying, this is pointless. What do you expect - to "convert" him?
LOL!Your logic sucks.Why does anyone listen to anyone on these boards?Why is my opinion less valuable because Im short? If I came out here and said PFE is buying PLX, its going to the moon!!! Everybody would cheer me on like a hero.Im not telling anyone what to do, dig into yourself, I'm just giving you a starting point.And by the way, Im up over $22k on my PLX short and options. By the time this hits the $5s I will be well over +$60k
MAYBE YOU BEND OVER TOO MUCH, BENDER
Nice 5th grade humor... very funny.Read my posts, I made of living shorting these drug launches. PLEASE read my history.You might learn somethingDAVE
nonesense!no taxes for 10 years on this companyno payment to PFE in IsraelMultiple very law for this new technology!
Bend over, bender.
So the only source of revenue for PLX forever will be the Gaucher'smarket?No other value to the company? Why is the penetration # so low?Silly analysis.
Ummmm lets a take a look:http://www.protalix.com/product-development/overview-product-development.aspOnly one drug in Ph1, the others in PRE-CLINICALSo, um, yah this is the onely money they will be gettign for $5+ years.Do some DD before you come on these boards and jus throw out garbage or belive the pumpers.